Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.4.4 (
kinesin
)
5,033
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In Xenopus, axis development is initiated by dorsally elevated levels of cytoplasmic beta-catenin, an intracellular factor regulated by GSK3 kinase activity. Upon fertilization, factors that increase beta-catenin stability are translocated to the prospective dorsal side of the embryo in a microtubule-dependent process. However, neither the identity of these factors nor the mechanism of their movement is understood. Here, we show that the GSK3 inhibitory protein
GBP
/Frat binds kinesin light chain (KLC), a component of the microtubule motor
kinesin
. Upon egg activation,
GBP
-GFP and KLC-GFP form particles and exhibit directed translocation. KLC, through a previously uncharacterized conserved domain, binds a region of
GBP
that is required for
GBP
translocation and for GSK3 binding, and competes with GSK3 for
GBP
. We propose a model in which conventional
kinesin
transports a
GBP
-containing complex to the future dorsal side, where
GBP
dissociates and contributes to the local stabilization of beta-catenin by binding and inhibiting GSK3.
...
PMID:GBP binds kinesin light chain and translocates during cortical rotation in Xenopus eggs. 1450 79